Participants
nonadherence, malignancy, cancer, oligoanuria
MALIGNANT NEOPLASM, CANCER, END-STAGE RENAL FAILURE, URINARY INFECTION
Nine male patients from the Urology Outpatient Clinic of HUMAP with a clinical and urodynamic diagnosis of DU were evaluated between November 2018 and July 2021. The individuals were informed about the purpose of the research, and those who agreed to participate signed the Free and Informed Consent Form (FICF).The inclusion criteria were male patients with a urodynamic study showing only DU without the presence of an obstructive factor to urinary flow, patients still undergoing intermittent clean catheterization, and patients who have not undergone any surgical procedure to the lower urinary tract in the last 12 months. The exclusion criteria were end-stage renal failure (with oligoanuria), recurrent urinary infection, nonadherence to clinical follow-up protocols, and nonadherence to intermittent clean self-catheterization. Additional exclusion criteria were the presence of a recently treated malignant neoplasm, malignancy confirmed in treatment, or suspected cancer, as these criteria were contraindications to the use of stem cells.